Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E Adjustments
Ratios

Actinium Pharmaceuticals (ATNM) Receivables - Other (2021 - 2023)

Actinium Pharmaceuticals (ATNM) has disclosed Receivables - Other for 4 consecutive years, with $307000.0 as the latest value for Q2 2023.

  • On a quarterly basis, Receivables - Other fell 21.68% to $307000.0 in Q2 2023 year-over-year; TTM through Jun 2023 was $307000.0, a 21.68% decrease, with the full-year FY2022 number at $302000.0, down 22.96% from a year prior.
  • Receivables - Other was $307000.0 for Q2 2023 at Actinium Pharmaceuticals, up from $304000.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $392000.0 in Q1 2021 to a low of $300000.0 in Q3 2022.
  • A 3-year average of $356500.0 and a median of $392000.0 in 2021 define the central range for Receivables - Other.
  • Biggest YoY gain for Receivables - Other was 0.0% in 2022; the steepest drop was 23.47% in 2022.
  • Actinium Pharmaceuticals' Receivables - Other stood at $392000.0 in 2021, then dropped by 22.96% to $302000.0 in 2022, then increased by 1.66% to $307000.0 in 2023.
  • Per Business Quant, the three most recent readings for ATNM's Receivables - Other are $307000.0 (Q2 2023), $304000.0 (Q1 2023), and $302000.0 (Q4 2022).